BONNIE BENDALL: Open Payments
NPI 1922310218 · RUSSELLVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 10 payments from 5 companies in 2025. Trend: 2023 $248 · 2024 $307 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Kerendia, REXULTI, MOUNJARO, CAPLYTA, AIRSUPRA, BREZTRI, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
